NLRP3 and neurodegenerative disease: Indeed, MCC950, a specific NLRP3 inhibitor, showed therapeutic effect in many neurodegenerative animal models.355,356 However, MCC950 is still not approved for the clinical usage as therapeutic method of neurodegenerative diseases.